In focus
Latest feed
India's Pharmaceutical Leap: From Generic Giant to Innovation Hub
Cipla Shares Poised for a Jump as Citi Flags Near‑Term US Growth Triggers
The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs
Aurobindo Pharma Scores Major USFDA Win with Generic Tofacitinib Tablets
